Phase II study of NK313 in malignant lymphomas: an NK313 Malignant Lymphoma Study Group trial

1993 ◽  
Vol 31 (6) ◽  
pp. 445-448 ◽  
Author(s):  
Takashi Yoshida ◽  
Makoto Ogawa ◽  
Kazuo Ota ◽  
Yutaka Yoshida ◽  
Akira Wakui ◽  
...  
Keyword(s):  
Malignant Lymphoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Study Group ◽  
Malignant Lymphomas ◽  
Lymphoma Study Group ◽  
Group Trial

Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group

2014 ◽  
Vol 166 (1) ◽  
pp. 69-76 ◽  
Author(s):  
Annarita Conconi ◽  
Markus Raderer ◽  
Silvia Franceschetti ◽  
Liliana Devizzi ◽  
Andrés J. M. Ferreri ◽  
...  
Keyword(s):  
B Cell ◽  
Phase Ii ◽  
Marginal Zone ◽  
Phase Ii Study ◽  
Extranodal Lymphoma ◽  
Clinical Activity ◽  
Study Group ◽  
B Cell Lymphomas ◽  
Lymphoma Study Group

Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402

2012 ◽  
Vol 51 (6) ◽  
pp. 768-773 ◽  
Author(s):  
Naoyuki Nogami ◽  
Katsuyuki Hotta ◽  
Yoshihiko Segawa ◽  
Nagio Takigawa ◽  
Shinobu Hosokawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Small Cell ◽  
Study Group ◽  
Small Cell Lung ◽  
Cancer Study Group ◽  
Lung Cancer Study Group ◽  
Group Trial
Sign in / Sign up

Export Citation Format

Share Document